TLDR Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.
In 2015, a pilot study was conducted on 15 patients with alopecia areata, a disease causing patchy hair loss. These patients had previously tried various treatments with no success. They underwent five sessions of treatment with triamcinolone acetonide, delivered to the scalp by microneedling, every 3 weeks. After 3 sessions, 8 out of 15 patients showed significant improvement, with the appearance of new hair and gradual conversion to normal hair. After 6 sessions, this number increased to 12. The study concluded that this treatment method can be effective for patients with alopecia areata.
July 2021 in “The Egyptian Journal of Hospital Medicine” Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.
19 citations,
April 2020 in “Journal of the American Academy of Dermatology” 5 mg/mL of triamcinolone acetonide is most effective for hair regrowth with fewer side effects.
50 citations,
July 2015 in “Journal of the American Academy of Dermatology” Using 2.5 mg/mL triamcinolone acetonide is effective for hair growth in alopecia areata with fewer side effects.
5 citations,
April 2015 in “HSOA journal of clinical dermatology & therapy” Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.
25 citations,
February 2014 in “British journal of dermatology/British journal of dermatology, Supplement” Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.
11 citations,
April 1997 in “International Journal of Dermatology” Using tretinoin with triamcinolone acetonide helps treat alopecia areata.
7 citations,
November 1996 in “PubMed” Triamcinolone regrows hair better but relapses more than anthralin.
75 citations,
September 1971 in “British Journal of Dermatology” Both steroids effectively promote hair growth for at least 9 months.
